Intracranial hemorrhage risk in patients with cerebral microbleeds after mechanical thrombectomy for acute ischemic

Tingting Guo1, Teng Ma2, Xuan Bai1

  • 1Department of Neurology, People's Hospital of Liaoning Province, Shenhe District, 33 Wenyi Road, Shenyang, 110016, People's Republic of China.

Insights

Cerebral microbleeds (CMBs) in acute ischemic stroke (AIS) patients undergoing mechanical thrombectomy do not increase hemorrhage risk unless 5 or more are present. Higher CMB burden correlates with hemorrhagic complications, but not symptomatic ICH.

Area of Science:

  • Neurology
  • Neurosurgery
  • Radiology

Background:

  • Mechanical thrombectomy is a key treatment for acute ischemic stroke (AIS).
  • Cerebral microbleeds (CMBs) are common in AIS patients and may influence post-treatment outcomes.
  • The association between CMBs and intracranial hemorrhage (ICH) risk after mechanical thrombectomy requires clarification.

Approach:

  • A systematic review and meta-analysis of studies investigating ICH risk in AIS patients with CMBs after mechanical thrombectomy.
  • Searched PubMed and Embase databases for relevant studies.
  • Calculated pooled odds ratios (ORs) for various ICH subtypes based on CMB presence, number (1-4 vs. ≥5), and location.

Key Points:

  • No significant association was found between CMB location (lobar, deep, infratentorial, mixed) and ICH risk.
  • CMB presence or 1-4 CMBs did not significantly increase the risk of any ICH, symptomatic/asymptomatic ICH, ICH outside infarct, subarachnoid hemorrhage, hemorrhagic infarction, or parenchymal hemorrhage.
  • CMBs ≥5 significantly increased the risk of any ICH (OR 2.58), parenchymal hemorrhage (OR 3.38), and parenchymal hemorrhage-2 (OR 5.33), but not hemorrhagic infarction or parenchymal hemorrhage-1.

Conclusions:

  • In AIS patients treated with mechanical thrombectomy, CMBs ≥5 are associated with increased ICH risk, particularly parenchymal hemorrhage.
  • Increased CMB burden correlates with hemorrhagic complications, but not specifically with symptomatic ICH.
  • Further research is needed to fully elucidate the risk associated with ≥5 CMBs and their impact on hemorrhagic complications.